6Clinical and Laboratory Standards Institute M100-S17. Performance standards for antimicrobial susceptibility testing; Seventeenth Informational Supplement. Wayne, PA2007.
7Pfaller MA, Sader HS, Fritsche TR, et al. Antimicrobial activity of cefepime tested against ceftazidime-resistant gram-negative clinical strains from North American hospitals: report from the SENTRY Antimicrobial Surveillance Program(1998-2004). Diagn Microbiol Infect Dis ,2006,56:63-68.
8Fritche TR, Sader HS, Jones RN. Potency and specrum of garenoxacin tested against an inter-national collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004). Diagn Microbiol Infect Dis,2007,58 : 19-26.
9McDonald LC. Trend in antimicrobial resistance in health care- associated pathogens and effect on treatment. Clin Infect Dis, 2006,42: S65-S71.
10Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement. Wayne, PA2007.
